AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇰🇪

Empagliflozin + Metformin Hydrochloride in Kenya

7 products registered with PPB — 7 active

Brand / ProductReg. No.HolderStatusExpires
Emjard M 5/500 Tablet
Tablet
H2025/CTD10992/24277Square Pharmaceuticals Ltd.active20 Jan 2030
GLIFEMPA XR
Tablet
H2022/CTD10089/22978GALAXY PHARMACEUTICAL LTDactive17 Oct 2028
Jardimet 5/500 Tablet
Film-Coated Tablet
H2022/CTD10147/22718Beximco Pharmaceuticals Limitedactive23 Jun 2028
Synjardy 12.5 + 1000 mg Tablets
Film-Coated Tablet
H2022/CTD8752/18255Boehringer Ingelheim international GmbHactive20 Nov 2027
Synjardy 5 / 850 mg Tablets
Film-Coated Tablet
H2022/CTD8753/18252Boehringer Ingelheim international GmbHactive13 Oct 2027
Synjardy 12.5 + 850 mg Tablets
Film-Coated Tablet
H2022/CTD8751/18254Boehringer Ingelheim international GmbHactive14 Sept 2027
Synjardy 5 / 1000 mg Tablets
Film-Coated Tablet
H2022/CTD8750/18253Boehringer Ingelheim international GmbHactive14 Sept 2027

Empagliflozin + Metformin Hydrochloride — PPB Registration Details

PPB (Kenya) has 7 registered products containing Empagliflozin + Metformin Hydrochloride, of which 7 are currently active. Data is sourced directly from the official PPB drug register and refreshed daily.

Track Empagliflozin + Metformin Hydrochloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.